期刊文献+

Radixin定点突变过表达对HepG2细胞膜转运蛋白Bsep的影响 被引量:2

Effect of radixin phosphorylation on bile salt export pump expression on HepG2 cell membrane
下载PDF
导出
摘要 目的构建pcDNA3.1-RDX定点突变真核过表达质粒,研究其在胆汁淤积时对HepG2细胞膜转运蛋白胆盐输出泵(bile salt export pump,Bsep)定位表达的影响。方法从含有RDX野生型质粒中,利用PCR方法钓取RDX野生型基因片段并以野生型为基础进行定点突变,PCR扩增后转入pcDNA3.1载体,其产物转化DH-5α感受态细胞。对长出的单克隆进行菌落PCR鉴定,再对PCR鉴定阳性的克隆进行测序和比对分析,比对正确即为构建成功的目的质粒。将目的质粒转染HepG2细胞,经G418筛选构建稳转细胞株。提取各株细胞的总蛋白,检测磷酸化RDX是否影响HepG2细胞膜上转运蛋白Bsep的表达。结果 PCR和测序结果均证实pcDNA3.1-RDX WT、pcDNA3.1-RDX T564D、pcDNA3.1-RDX T564A过表达载体构建成功。蛋白免疫印迹表明,与转染pcDNA-3.1-RDX-WT的HepG2相比,转染pcDNA-3.1-T564D的HepG2的Bsep膜蛋白表达量显著增加(P<0.05),而转染pcDNA-3.1-T564A的HepG2的Bsep膜蛋白表达量有所下降(P>0.05)。结论成功构建了pcDNA3.1-RDX WT、pcDNA3.1-RDX T564D、pcDNA3.1-RDX T564A过表达载体,并证实RDX的磷酸化能增强HepG2细胞膜上Bsep的表达。 Objective To construct radixin (RDX) wild type and mutant over-expression vectors, pcDNA3.1-RDX WT, pcDNA3.1-RDX T564D, and pcDNA3. I-RDX T564A, and to study the effects of RDX phosphorylation on bile salt export pump (Bsep) expression of HepG2 cell membrane. Methods RDX wild type gene was used as template to carry out point mutation, T564D and T564A. All target DNAs were trans- ferred to pcDNA3.1 to construct 3 over-expression vectors, pcDNA3. 1-RDX WT, pcDNA3. 1-RDX T564D, and pcDNA3.1-RDX T564A. DH-Set competent cells were transformed with the recombinant plasmids for posi- tive clone identification. Then target clones were used to transfect HepG2 cells and stable cell lines were estab- lished. Western blotting was used to confirm the expression of RDX, p-Thr564-RDX and Bsep. Results All the recombinant plasmids were correctly constructed. Western blot results demonstrated that the cell membrane Bsep expression was slightly higher in HepG2 cells transfected with pcDNA3.1-RDX WT than in the cells transfected with pcDNA-3. 1-RDX T564A ( P 〉 0. 05 ) and significantly lower than in the cells transfected with pcDNA3.1-RDX T564D (P 〈 0. 05). Conclusion RDX wild type and mutant over-expression vectors are successfully constructed. RDX phosphorylation improves Bsep expression on HepG2 cell membrane.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2014年第10期1002-1007,共6页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(81370560 81170430) 国家自然科学基金青年科学基金(81100280)~~
关键词 RDX定点突变 载体构建 PCDNA3 1载体 胆盐输出泵 radixin phosphorylation mutant vector construction pcDNA3. I bile salt export pump
  • 相关文献

参考文献26

  • 1Stieger B,Meier Y,Meier P J.The bile salt export pump [J].Pflugers Arch,2007,453(5):611-620.
  • 2Soroka C J,Boyer J L.Biosythesis and trafficking of the bile salt export pump,Bsep:Therapeutic implications of Bsep mutations [J].Mol Aspects Med,2013,pii:S0098-2997(13)00034-4.[Epub ahead of print].
  • 3dada M,Canals D,Hannun Y A,et al.Sphingolipid regulation of ezrin,radixin,and moesin proteins family:Implications for cell dy-namics[J].Biochim Biophys Acta,2014,1841(5):727-737.
  • 4Kmbitz R,Droge C,Stindt J,et at.The bile salt export pump(Bsep)in health and disease[J].Clin Res Hepatol Gastroenterol,2012,36(6):536-553.
  • 5白阳,冯义朝.BSEP的调控及其突变与胆汁淤积性肝病的关系[J].医学信息,2013(3):326-327. 被引量:3
  • 6Neisch A L,Fehon R G.Ezrin,Radixin and Moesin:key regulators of membrane-cortex interactions and signaling [J].Curr Opin Cell Biol,2011,23(4):377-382.
  • 7Niggli V,Rossy J.Ezrin/radixin/moesin:versatile controllers of signa-ling molecules and of the cortical cytoskeleton [J].Int J Biochem Cell Biol,2008,40(3):344-349.
  • 8Maniti O,Carvalho K,Picart C.Model membranes to shed light on the biochemical and physical properties of ezrin/radixin/moesin [J].Bio-chimie,2013,95(1):3-11.
  • 9Kikuchi S,Hata M,Fukumoto K,et al.Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes [J].Nat Genet,2002,31(3):320-325.
  • 10Fukumoto K,Kikuchi S,Itoh N,et al.Effects of genetic back-grounds on hyperbilirubinemia in radixin-deficient mice due to differ-ent expression levels of Mrp3 [J].Biochim Biophys Acta,2007,1172(3):298-306.

二级参考文献31

  • 1Hasegawa Y,Kishimoto S,Takahashi H,et al. Altered expression ofMRP2, MRP3 and UGT2B1 in the liver affects the disposition of mor-phine and its glucuronide conjugate in a rat model of cholestasis[ J]. JPharm Pharmacol, 2009,61(9) : 1205 -1210.
  • 2Teng S, Piquette-Miller M. Hepatoprotective role of PXR activationand MRP3 in cholic acid-induced cholestasis [ J]. Br J Pharmacol,2007,151(3): 367 -376.
  • 3Keppler D. Cholestasis and the role of basolateral efflux pumps [J]. ZGastroenterol, 2011,49(12) : 1553 -1557.
  • 4Schaap F G, van-der-Gaag N A, Gouma D J, ef al. High expression ofthe bile salt-homeostatic hormone fibroblast growth factor 19 in the liverof patients with extrahepatic cholestasis [ J]. Hepatology, 2009,49(4): 1228 -1235.
  • 5Bohan A, Chen W S, Denson L A, ef al. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3 ( Abcc3) reduces liver inju-ry in obstructive cholestasis[ J]. J Biol Chem, 2003,278(38) : 36688-36698.
  • 6Zollner G, Fickert P, Silbert D,et al. Adaptive changes in hepatobili-ary transporter expression in primary biliary cirrhosis[ J]. J Hepatol,2003, 38(6) : 717 -727.
  • 7Donner M G,Warskulat U,Saha N, et al. Enhanced expression of ba-solateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liv-er by LPS[J]. Biol Chem, 2004, 385(3/4) : 331 -339.
  • 8Chai J,He Y, Cai S Y, et al. Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression inhuman obstructive cholestasis is mediated through tumor necrosis factoralpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway[ J]. Hepatology, 2012,55(5) : 1485 - 1494.
  • 9Chen W, Cai SY, Xu S, et al. Nuclear receptors RXHalpha: RARal-pha are repressors for human MRP3 expression[ J]. Am J Physiol Gas-trointest Liver Physiol, 2007, 292(5) : G1221 -G1227.
  • 10Jigorel E, Le-Vee M, Boursier-Neyret C, et al. Differential regulationof sinusoidal and canalicular hepatic drug transporter expression by xe-nobiotics activating drug-sensing receptors in primary human hepato-cytes[ J]. Drug Metab Dispos, 2006, 34( 10) : 1756 - 1763.

共引文献8

同被引文献34

  • 1杨慧玲,刘建全.9种“藏茵陈”原植物中的7种有效化学成分研究[J].中草药,2005,36(8):1233-1237. 被引量:28
  • 2Pauli-Magnus C, Meier P J. Hepatocellular transporters and cholestasis[J]. J Clin Gastroenterol, 2005, 39(4 Suppl 2): S103-S110.
  • 3Padda M S, Sanchez M, Akhtar A J, et al. Drug-induced cholestasis[J]. Hepatology, 2011, 53(4): 1377-1387.
  • 4Wagner M, Zollner G, Trauner M. Nuclear receptors in liver disease[J]. Hepatology, 2011, 53(3): 1023-1034.
  • 5Traauner M, Boyer J L. Cholestatic syndromes[J]. Curr Opin Gastroenterol, 2002, 18(3): 314-329.
  • 6Chiang J Y. Bile acids: regulation of synthesis[J]. J Lipid Res, 2009, 50(10): 1955-1966.
  • 7Claudel T, Zollner G, Wagner M, et al. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease[J]. Biochim Biophys Acta, 2011, 1812(8): 867-878.
  • 8Chai J, He Y, Cai S Y, et al. Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway[J]. Hepatology, 2012, 55(5): 1485-1494.
  • 9Chai J1, Luo D, Wu X, et al. Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis[J]. J Gastrointest Surg, 2011, 15(6): 996-1004.
  • 10Sampath J, Adachi M, Hatse S, et al. Role of MRP4 and MRP5 in biology and chemotherapy[J]. AAPS PharmSci, 2002, 4(3): E14.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部